Science & Enterprise subscription

Follow us on Twitter

  • Wish it weren't needed, but ...
    about 2 days ago
  • The Edelman public relations agency released results of a survey earlier this month gauging the public's awareness…
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Public, Tech Execs Differ on A.I. Use #Science #Business
    about 2 days ago
  • New contributed post on Science and Enterprise: Keeping Information Safe in the Internet Age
    about 2 days ago
  • Engineers in Germany designed screens for mobile phones and tablets that not only feel touch pressure, but can also…
    about 3 days ago

Please share Science & Enterprise

Follow by Email
Visit Us

Infographic – Growing Interest in Longevity Research

Chart: human longevity references

News references to terms related to human longevity, Sept 2013 to Aug. 2018. Click on chart for full-size view. (CB Insights)

3 Nov. 2018. Most of the reporting in Science & Enterprise is about biomedical research and development, with much of that work addressing the needs of an aging population worldwide.In fact, a company founded by genomics pioneer J. Craig Venter has the name Human Longevity Inc., on which we reported several times, including earlier this year. And this interest in extending people’s lifetimes, as well as improving the quality of their lives, drives much of the venture and other business investment in R&D.

Our friends at the technology intelligence company CB Insights also reported recently on this phenomenon, with a chart from that report showing a growing journalistic interest in topics related to human longevity, this weekend’s infographic. The graphic displays the number of news references citing terms like senescence — the process of deterioration due to age — or age-related diseases between September 2013 and August 2018. The data show two big spikes in interest, in early 2017 and just this past year.

This growing interest is also reflected by investors. The links below from recent Science & Enterprise stories offer examples of those investments just in neurodegenerative disorders associated with aging, reaching in some cases into billions of dollars.

More from Science & Enterprise:

*     *     *

Please share Science & Enterprise ...

Comments are closed.